{"id":"CHEMBL101740","canonicalSmiles":"CN(C)CC/C=C1/c2ccccc2COc2ccccc21","inchiKey":"ODQWQRRAPPTVAG-BOPFTXTBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIDOXEPIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cidoxepin"],"crossReferences":{"Wikipedia":["Doxepin"],"drugbank":["DB14750"],"chEBI":["36691"]},"childChemblIds":["CHEMBL1256774"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1042","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C","inchiKey":"QYSXJUFSXHHAJI-YRZJJWOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLECALCIFEROL","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accrete d3","Aciferol d3","Adcal-d3","Aviticol","Bio-vitamin d3","Biolife vitamin d3","Cacit d3","Calceos","Calci-d","Calcichew d3","Calcichew d3 fte","Calcichew d3 once daily","Caldrink d3","Calfovit d3","Colecal d3","Colecalciferol","Colekal-d3","Colevit d3","Cubicole d3","D-max","D-tracetten","D-vit3","D3 lemon melts","D3-50","Dekristol","Desunin","Dihydrocholesterol","Dlux 400","E-d3","Evacal d3","Fultium daily d3","Fultium-d3","Hux d3","Invita d3","Iso d3","Kora liquid","Natecal d3","Nature's remedy vitamin d3","Neo-d","Nphd3","Osteocaps d3","Plenachol","Pro d3","Pro d3 folic","Pro d3 forte","Royalvit d3","Stexerol-d3","Stivit-d3","Sunvit-d3 1,000","Sunvit-d3 10,000","Sunvit-d3 2,000","Sunvit-d3 20,000","Sunvit-d3 3,000","Sunvit-d3 400","Sunvit-d3 5,000","Sunvit-d3 50,000","Sunvit-d3 800","Synervit-d3","Theical d-3","Thorens","Vigantol","Vigantoletten","Vigantoletten 500","Vit d3 streuli","Vita-d3","Vitamin D 3","Zymad"],"synonyms":["7-dehydrocholesterol, activated","AK R215 COMPONENT COLECALCIFEROL","AK-R215 COMPONENT COLECALCIFEROL","Cholecalciferol","Colecalciferol","NSC-375571","Vitamin d","Vitamin d assay system suitability","Vitamin d3"],"crossReferences":{"DailyMed":["cholecalciferol"],"PubChem":["144205131","144209744","17388665","26754459","29215239"],"Wikipedia":["Cholecalciferol"],"drugbank":["DB00169"],"chEBI":["28940"]},"count":97,"approvedIndications":["EFO_0004272","EFO_0003882","HP_0001891"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0000365","EFO_0000555","EFO_0000756","EFO_0003762","HP_0011950","EFO_1001951","EFO_0003964","EFO_1000653","HP_0100543","EFO_0003931","EFO_0002690","EFO_0003884","EFO_0000676","EFO_0004616","EFO_1000961","EFO_0000400","EFO_0009686","EFO_0000180","EFO_0005583","EFO_0003758","MONDO_0002363","Orphanet_636","MONDO_0002508","EFO_0000384","MONDO_0008315","EFO_0000660","EFO_0002496","GO_0007568","EFO_1000049","Orphanet_101997","EFO_0007328","EFO_0000341","Orphanet_43","EFO_0004248","HP_0002901","EFO_0007405","EFO_0005878","MONDO_0007254","Orphanet_586","EFO_0003882","MONDO_0002050","MONDO_0002898","EFO_0002546","EFO_0000694","EFO_0000280","EFO_0000616","EFO_0004261","EFO_0000765","EFO_0008572","EFO_0000222","EFO_0003929","EFO_0000319","EFO_0001073","EFO_0000537","EFO_0000195","EFO_0003885","EFO_1001121","EFO_0000764","EFO_0007141","EFO_0005411","EFO_0000519","EFO_0003956","EFO_0004265","EFO_0000729","EFO_0003095","EFO_0005406","HP_0001268","EFO_1000657","EFO_0003774","EFO_0005681","HP_0000938","EFO_0004593","EFO_0002506","EFO_0000544","EFO_0000692","Orphanet_145","EFO_0002508","MONDO_0008170","EFO_0000701","Orphanet_3389","EFO_0009516","MONDO_0044881","Orphanet_309005","HP_0002110","MP_0001845","MONDO_0100096","EFO_0008506","EFO_0000270","EFO_0001359","EFO_0000432","EFO_0000342","EFO_0001360","EFO_0003785","Orphanet_232","EFO_0001065","EFO_0009531","EFO_0000274","MONDO_0021063","EFO_0002950","MONDO_0002146","EFO_0000474","EFO_0005531","EFO_0003144","EFO_0000673","EFO_0004272","EFO_0003047","EFO_0003917","MONDO_0004647","EFO_0008521","Orphanet_666","EFO_0007214","EFO_0002609","EFO_0000311","EFO_0003106","EFO_0000095","EFO_0003854","EFO_0003766","EFO_1001029","EFO_0003944","HP_0001891"],"count":121},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 94 investigational indications."}
{"id":"CHEMBL1072","canonicalSmiles":"CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1","inchiKey":"MAEIEVLCKWDQJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUMETANIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betinex","Bumetanide","Bumex","Burinex","Lixil"],"synonyms":["Bumetanide","RO 10-6338","RO-10-6338","RO-106338","S-95008.","S95008."],"crossReferences":{"DailyMed":["bumetanide"],"PubChem":["11110843","11110844","144203639","170464735","26746951","26751481","50103991","56424138","855675"],"Wikipedia":["Bumetanide"],"drugbank":["DB00887"],"chEBI":["3213"]},"count":11,"approvedIndications":["EFO_0003086","EFO_0003144","EFO_0004255","EFO_0000373","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000074803"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003756","EFO_0003144","EFO_0000182","EFO_0003884","EFO_0004255","EFO_0003758","EFO_0000373","EFO_0000319","Orphanet_681","HP_0001250","EFO_0001360"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 5 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL107251","canonicalSmiles":"CC(=N)NCc1cccc(CN)c1","inchiKey":"RODUKNYOEVZQPR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1400W","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111967","11114075","124881823","26752186","26752187","50104843","50104844"],"drugbank":["DB02044"],"chEBI":["90721"]},"childChemblIds":["CHEMBL544788"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1078535","canonicalSmiles":"Cc1ccc2c(c1)CCCN2C(=O)SCC(=O)Nc1ccc(S(N)(=O)=O)cc1Cl","inchiKey":"AWAKIULNKVOBKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1078535","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08494"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1079175","canonicalSmiles":"NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1","inchiKey":"ULDXWLCXEDXJGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-2206","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-2206","MK2206","Mk-2206"],"crossReferences":{"PubChem":["124897541","124897542","144206919","170466896"],"chEBI":["67271"]},"count":21,"linkedTargets":{"rows":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000756","EFO_0000681","EFO_0000403","MONDO_0007254","EFO_1000657","EFO_0004252","MONDO_0021063","EFO_0000308","EFO_0000305","EFO_0003060","EFO_0001663","EFO_0000311","MONDO_0015917","EFO_1000044","EFO_0006861","EFO_0000095","MONDO_0008903","MONDO_0011962","EFO_0000182","EFO_0000233","EFO_0003050","EFO_0000181"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 21 investigational indications."}
{"id":"CHEMBL109480","canonicalSmiles":"C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\\C=C(/C)C(=O)NC(=CC1=O)C2=O","inchiKey":"AYUNIORJHRXIBJ-TXHRRWQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANESPIMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17-AAG","BMS-722782","CNF-1010","CNF1010","KOS-953","NSC-330507","Tanespimycin"],"crossReferences":{"PubChem":["144205607","26756800","26756801","574817"],"Wikipedia":["Tanespimycin"],"drugbank":["DB05134"],"chEBI":["64153"]},"count":38,"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0000637","MONDO_0019471","EFO_0000756","MONDO_0044887","MONDO_0007254","EFO_0000255","EFO_1001469","EFO_0000333","MONDO_0001187","EFO_1001951","EFO_0000565","EFO_0000309","MONDO_0001056","EFO_1000044","MONDO_0002225","EFO_0000389","MONDO_0008903","EFO_0000673","EFO_0000641","MONDO_0015277","EFO_0000183","EFO_1000785","EFO_0002914","EFO_0009441","EFO_0000616","MONDO_0001852","EFO_0006859","MONDO_0019465","MONDO_0008170","EFO_0000403","MONDO_0021038","MONDO_0008315","EFO_0000311","EFO_1001365","EFO_0003032","MONDO_0001023","EFO_0000095","EFO_0000191","EFO_0000574","MONDO_0002367","EFO_1001051","EFO_0001378","MONDO_0018906","EFO_0002428","EFO_1000550"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 38 investigational indications."}
{"id":"CHEMBL1112","canonicalSmiles":"O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1","inchiKey":"CEUORZQYGODEFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ARIPIPRAZOLE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abilify","Abilify maintena","Abilify maintena kit","Abilify mycite kit","Aripiprazole"],"synonyms":["Aripiprazole","OPC-14597","OPC-31"],"crossReferences":{"DailyMed":["aripiprazole"],"PubChem":["144205281","170465392","174006897","26719891","29215485","49666418"],"Wikipedia":["Aripiprazole"],"drugbank":["DB01238"],"chEBI":["31236"]},"count":24,"approvedIndications":["EFO_0000289","MONDO_0002050","MONDO_0002009","EFO_0003015","EFO_0003758","EFO_0003761","EFO_0005407","EFO_0000692","EFO_0005411","HP_0000713"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000149295","ENSG00000102468"],"count":3},"linkedDiseases":{"rows":["EFO_0004566","EFO_0002610","MONDO_0002009","EFO_0004216","EFO_0007453","EFO_0000249","HP_0000726","EFO_0003015","EFO_0003757","EFO_1001917","EFO_0003829","EFO_0000289","MONDO_0002050","EFO_0004714","EFO_0007319","EFO_0003761","EFO_0009854","EFO_0004701","EFO_0004242","MONDO_0000594","EFO_0005230","EFO_0000692","EFO_0004215","EFO_0003888","EFO_0003756","EFO_0005203","EFO_0000677","EFO_0003758","EFO_1000904","EFO_0009963","EFO_0005407","EFO_0001358","Orphanet_908","HP_0000713","EFO_0008623","MONDO_0002491","EFO_0004895","EFO_0005411"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 10 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1121","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"IZTQOLKUZKXIRV-YRVFCXMDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SINCALIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kinevac"],"synonyms":["Cholecystokinin","Cholecystokinin c-terminal octapeptide","Pancreozymin","SQ 19844","SQ-19844","Sincalide"],"crossReferences":{"DailyMed":["sincalide"],"PubChem":["144206508","144207030"],"Wikipedia":["Sincalide"],"drugbank":["DB09142"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL11359","drugType":"Small molecule","blackBoxWarning":true,"name":"CISPLATIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2068237","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cisplatin","Platinol","Platinol-aq"],"synonyms":["CIS-DDP","Cis-platinum ii","Cisplatin","Cisplatinum","INT-230-6 COMPONENT CISPLATIN","INT230-6 COMPONENT CISPLATIN","Liplacis","NSC-119875","cis-diamminedichloroplatinum(II)"],"crossReferences":{"DailyMed":["cisplatin"],"DrugCentral":["4392"],"PubChem":["17389100","301178","50105439","557830","90340859"]},"count":161,"approvedIndications":["EFO_0000616","EFO_0000311"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for neoplasm and cancer and has 159 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL115220","canonicalSmiles":"O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1","inchiKey":"RIGZCVNCFXYBEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL115220","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06944"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1166","canonicalSmiles":"CC1CNc2c(cccc2S(=O)(=O)N[C@@H](CCCNC(=N)N)C(=O)N2CC[C@@H](C)C[C@@H]2C(=O)O)C1","inchiKey":"KXNPVXPOPUZYGB-IOVMHBDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGATROBAN","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acova","Argatroban","Argatroban in dextrose","Argatroban in sodium chloride"],"synonyms":["Argatroban","Argatroban hydrate","Argatroban monohydrate","DK-7419","GN-1600","GN1600","MCI-9038","MD-805"],"crossReferences":{"DailyMed":["argatroban"],"Wikipedia":["Argatroban"],"drugbank":["DB00278"]},"count":3,"approvedIndications":["HP_0004419","HP_0001873"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["HP_0002140","MONDO_0100096","EFO_1000985","MONDO_0000831","EFO_0000712","EFO_0003884","EFO_0000319","HP_0004419","HP_0001873"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for thrombocytopenia and recurrent thrombophlebitis and has 1 investigational indication."}
{"id":"CHEMBL1185568","canonicalSmiles":"CCN1C(=CC=CC=Cc2sc3ccccc3[n+]2CC)Sc2ccccc21","inchiKey":"FYXWDSGGZAMYFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITHIAZANINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," France"],"classes":["Cardiotoxicity"," Metabolism toxicity"],"year":1964},"tradeNames":[],"synonyms":["Dithiazanine"],"crossReferences":{"PubChem":["124893646","50125814","50125815"],"drugbank":["DB11516"],"chEBI":["52787"]},"childChemblIds":["CHEMBL2357179","CHEMBL421701"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States and  France initially in 1964 due to Cardiotoxicity and  Metabolism toxicity."}
{"id":"CHEMBL1190199","canonicalSmiles":"CN(C(=O)C(c1ccccc1)c1ccccc1)[C@H](CN1CC[C@H](O)C1)c1ccccc1","inchiKey":"JHLHNYVMZCADTC-LOSJGSFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASIMADOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asimadoline","EMD-61753"],"crossReferences":{"Wikipedia":["Asimadoline"],"drugbank":["DB05104"]},"childChemblIds":["CHEMBL540342"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1200802","canonicalSmiles":"C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O","inchiKey":"BJVVMKUXKQHWJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALBUTAL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lotusate"],"synonyms":["Talbutal"],"crossReferences":{"PubChem":["170465408"],"Wikipedia":["Talbutal"],"drugbank":["DB00306"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200862","canonicalSmiles":"C[C@](N)(Cc1ccc(O)cc1)C(=O)O","inchiKey":"NHTGHBARYWONDQ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METYROSINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Demser"],"synonyms":["L-588357-0","MK-781","Metirosine","Metyrosine"],"crossReferences":{"DailyMed":["metyrosine"],"PubChem":["170465112","29215162","50106644","50106645","50106646","90341393"],"Wikipedia":["Metirosine"],"drugbank":["DB00765"],"chEBI":["6912"]},"count":2,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000180176"],"count":1},"linkedDiseases":{"rows":["EFO_0005407","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for hypertension and has 1 investigational indication."}
{"id":"CHEMBL1201","canonicalSmiles":"CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1","inchiKey":"GFBKORZTTCHDGY-UWVJOHFNSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIOTHIXENE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navane","Orbinamon","Thiothixene"],"synonyms":["P-4657 B","P-4657B","Thiothixene","Tiotixene"],"crossReferences":{"DailyMed":["thiothixene"],"PubChem":["11532885","50111253"],"Wikipedia":["Thiothixene"],"drugbank":["DB01623"]},"childChemblIds":["CHEMBL1200902","CHEMBL3989824"],"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967 and is indicated for psychosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201184","canonicalSmiles":"CC(=O)O.CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O","inchiKey":"DEXPIBGCLCPUHE-UISHROKMSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LANREOTIDE ACETATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201185","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Somatuline depot"],"synonyms":["BIM-23014C","Lanreotide acetate"],"crossReferences":{"DailyMed":["lanreotide%20acetate"]},"count":2,"approvedIndications":["EFO_1001485"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000180616"],"count":2},"linkedDiseases":{"rows":["EFO_1001485","MONDO_0024503"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for acromegaly and has 1 investigational indication."}
{"id":"CHEMBL1201224","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1","inchiKey":"HJJDBAOLQAWBMH-YCRCPZNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMENOXIME","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefmenoxime"],"crossReferences":{"Wikipedia":["Cefmenoxime"],"drugbank":["DB00267"],"chEBI":["55490"]},"childChemblIds":["CHEMBL3183193"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and is indicated for bacterial disease."}
{"id":"CHEMBL1201291","canonicalSmiles":"CNC(=O)c1c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c2I)c(I)c(N(C)C(C)=O)c1I","inchiKey":"TYYBFXNZMFNZJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOXAGLIC ACID","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ioxaglate","Ioxaglic acid","P-286"],"crossReferences":{"PubChem":["11112801","144204215","56463674"],"Wikipedia":["Ioglicic_acid","Ioxaglic_acid"],"drugbank":["DB09313"],"chEBI":["31718"]},"childChemblIds":["CHEMBL1200743","CHEMBL1200508"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1201439","drugType":"Antibody","blackBoxWarning":true,"name":"BASILIXIMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Simulect"],"synonyms":["Basiliximab","CHI-621","SDZ-CHI-621"],"crossReferences":{"DailyMed":["basiliximab"],"DrugCentral":["4940"],"Wikipedia":["Basiliximab"]},"count":21,"approvedIndications":["EFO_0000540"],"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000729","EFO_0003086","EFO_0002687","EFO_0000464","EFO_0000222","EFO_0004236","MONDO_0002462","EFO_1000794","EFO_0000540","EFO_0004599","Orphanet_567","EFO_0001422","EFO_1001231","EFO_0000544","EFO_0001359","EFO_0003884","MONDO_0019472","EFO_1001226","EFO_0000253","EFO_0001378","EFO_0000183","EFO_0000400","Orphanet_231214","EFO_0000519","EFO_0001062"],"count":26},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for immune system disease and has 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201533","drugType":"Protein","blackBoxWarning":false,"name":"THYROTROPIN ALFA","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Thyrogen"],"synonyms":["GX-30","Thyrotropin alfa"],"crossReferences":{"DailyMed":["thyrotropin%20alfa"],"DrugCentral":["4930"]},"count":5,"approvedIndications":["EFO_0003841","EFO_0002892","MONDO_0002108"],"linkedTargets":{"rows":["ENSG00000165409"],"count":1},"linkedDiseases":{"rows":["EFO_0003841","MONDO_0002108","EFO_1001062","EFO_0002892","EFO_0004237","EFO_0004705"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL1201584","drugType":"Antibody","blackBoxWarning":false,"name":"ABCIXIMAB","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Reopro"],"synonyms":["Abciximab","Abciximab (genetical recombination)","C7E3"],"crossReferences":{"DrugCentral":["4950"],"Wikipedia":["Abciximab"]},"count":8,"approvedIndications":["EFO_1000985","HP_0004419"],"linkedTargets":{"rows":["ENSG00000259207"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001645","EFO_0002615","EFO_1001045","EFO_0003913","EFO_0008585","EFO_1000985","EFO_0000712","MONDO_0005299","EFO_0008583","EFO_0000612","HP_0004419","HP_0031273","EFO_0005672"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for intermediate coronary syndrome and recurrent thrombophlebitis and has 6 investigational indications."}
{"id":"CHEMBL1201761","canonicalSmiles":"Cl.N[C@@H]1CCCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2Cl)C1","inchiKey":"PMQBICKXAAKXAY-HNCPQSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BESIFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201760","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Besivance"],"synonyms":["BOL-303224-A","Besifloxacin hydrochloride","SS-734","SS734"],"crossReferences":{"DailyMed":["besifloxacin%20hydrochloride"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 2 investigational indications."}
{"id":"CHEMBL1201822","drugType":"Enzyme","blackBoxWarning":false,"name":"GALSULFASE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aryplase","Naglazyme"],"synonyms":["Arylsulfatase b galsulfase","Galsulfase"],"crossReferences":{"DailyMed":["galsulfase"],"DrugCentral":["5101"]},"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2005 and has 1 investigational indication."}
{"id":"CHEMBL1205948","canonicalSmiles":"O=C(O)CCCCO","inchiKey":"PHOJOSOUIAQEDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1205948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04781"],"chEBI":["45564"]},"childChemblIds":["CHEMBL170082"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208646","canonicalSmiles":"Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)O","inchiKey":"HXSKWEQQPCKYIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEOPHYLLINE GLYCINATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1200578"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL12089","canonicalSmiles":"COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]","inchiKey":"VKJGBAJNNALVAV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BERBERINE CHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL295124","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Berberine chloride","Berberine hydrochloride","GNF-Pf-4545","NSC-163088","NSC-646666"],"crossReferences":{"PubChem":["144204025","144207546","170465752","17389149","22405506","26748406","561883","56463133"],"Wikipedia":["Berberine"],"chEBI":["31271"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1213406","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCc1nnn[nH]1","inchiKey":"DEOJDUHRJBKATO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213406","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4263362"],"drugbank":["DB07055"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1214643","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(O[11CH3])c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2","inchiKey":"LGGHDPFKSSRQNS-KTXUZGJCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]TARIQUIDAR","maximumClinicalTrialPhase":0,"parentId":"CHEMBL348475","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[11C]-Tariquidar"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12198","canonicalSmiles":"CC(N)C(=O)O","inchiKey":"QNAYBMKLOCPYGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alanine","E639","L-alanine","NSC-206315"],"crossReferences":{"chEBI":["16449"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1232343","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H]1O","inchiKey":"PHTAQVMXYWFMHF-QVPNGJTFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232343","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04678"],"chEBI":["42088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234621","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@](O)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"SQVRNKJHWKZAKO-YRMXFSIDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Alpha-Sialoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Sialoside"],"crossReferences":{"Wikipedia":["Neuraminic_acid"],"drugbank":["DB03721"],"chEBI":["49026"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234750","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O","inchiKey":"KFEUJDWYNGMDBV-RCBHQUQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234750","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235228","canonicalSmiles":"C=C(OP(=O)(O)O)C(=O)O","inchiKey":"DTBNBXWJWCWCIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOENOLPYRUVATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxo-Phosphonooxy-Acetic Acid"],"crossReferences":{"drugbank":["DB01819"],"chEBI":["44897"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235900","canonicalSmiles":"CC(=O)[C@@H](N)COCc1ccccc1","inchiKey":"ISLRAQPEXPIKDJ-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"O-BENZYL-l-SERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02148"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1254682","canonicalSmiles":"C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13","inchiKey":"OZYUPQUCAUTOBP-QXAKKESOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVALLORPHAN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levallorphan","Lorfan","Naloxiphan"],"crossReferences":{"PubChem":["144205558","170465778"],"Wikipedia":["Levallorphan"],"drugbank":["DB00504"],"chEBI":["6431"]},"childChemblIds":["CHEMBL2062276"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1256842","canonicalSmiles":"CN1Cc2c(N)cccc2C(c2ccccc2)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"GEOCVSMCLVIOEV-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOMIFENSINE MALEATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL273575","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Spain"," Germany"," France"],"classes":["Hematological toxicity"," Hepatotoxicity"],"year":1986},"tradeNames":["Merital"],"synonyms":["HOE 984","Nomifensine maleate"],"crossReferences":{"PubChem":["170466450","26747597","26747598","50106723","50106724","50106725","855660","93576623"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. It was withdrawn in United States,  United Kingdom,  United States,  Spain,  Germany and  France initially in 1986 due to Hematological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL1276678","canonicalSmiles":"CN[C@H](CNC(=O)N1CCC[C@@H]([C@@H](OCCNC(=O)OC)c2cccc(Cl)c2)C1)C[C@H]1CCCOC1","inchiKey":"NXWASIVXQMMPLM-ZXMXYHOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VTP-27999","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vtp-27999"],"crossReferences":{"drugbank":["DB12416"]},"childChemblIds":["CHEMBL2023125"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1354199","canonicalSmiles":"C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"CXYRUNPLKGGUJF-RAFJPFSSSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHSCOPOLAMINE BROMIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL376897","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methscopolamine bromide","Pamine","Pamine forte"],"synonyms":["(-)-Scopolamine Methyl Bromide","Epoxytropine tropate methylbromide","Holopon","Hyoscine methobromide","Methscopolamine bromide","Methylscopolamine bromide","N-methylscopolamine methylsulfate","NSC-120606","Scopolamine methyl bromide","Scopolamine methylbromide"],"crossReferences":{"DailyMed":["methscopolamine%20bromide"],"PubChem":["11532979","144203588","170464623"],"chEBI":["61276"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1356607","canonicalSmiles":"NC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"WNPNNLQNNJQYFA-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOREPINEPHRINE BITARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Adrenor","Aktamin","Levarterenol Bitartrate","Levophed","Noradrenaline"],"synonyms":[],"crossReferences":{"PubChem":["50105827"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1378207","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.O.[Na+]","inchiKey":"HEIRCJNUUKDFDB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1378207","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56422374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1396","canonicalSmiles":"c1cnc2cc3c(cc2n1)C1CNCC3C1","inchiKey":"JQSHBVHOMNKWFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARENICLINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CP-526,555","CP-526555","Chantix","Varenicline"],"crossReferences":{"DailyMed":["varenicline%20tartrate"],"PubChem":["174007164"],"drugbank":["DB01273"]},"childChemblIds":["CHEMBL1201135","CHEMBL556954","CHEMBL2358534","CHEMBL2062259"],"count":19,"approvedIndications":["EFO_0003768"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","Orphanet_98757","EFO_0002610","EFO_0004329","EFO_0002508","EFO_0001645","EFO_0000249","EFO_0003768","EFO_0000313","EFO_0001071","Orphanet_95","EFO_0003829","EFO_0000311","EFO_0007191","EFO_0003890","MONDO_0002491","EFO_0006344","EFO_0000270","MONDO_0008903","EFO_0004701","EFO_0005411","EFO_0000692","EFO_0005672"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for nicotine dependence and has 18 investigational indications."}
{"id":"CHEMBL1408594","canonicalSmiles":"CCN(CCCc1ccccc1)CCCc1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"RYHCACJBKCOBTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVERINE CITRATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL253371","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Audmonal","Gielism","Relaxyl","Spasmonal","Spasmonal fte"],"synonyms":["Alverine citrate","NSC-35459","Phenpropamine citrate"],"crossReferences":{"PubChem":["11112963","124882741","144204308","170466248","26747847","26747848","56422383","855991"],"chEBI":["53785"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1533","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC","inchiKey":"RPLCPCMSCLEKRS-BPIQYHPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOGESTREL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aizea","Cerazette","Cerelle","Desomono","Feanolla","Nacrez","Zelleta"],"synonyms":["Desogestrel","ORG 2969","ORG-2969"],"crossReferences":{"DailyMed":["desogestrel"],"PubChem":["144206006","50112703"],"Wikipedia":["Desogestrel"],"drugbank":["DB00304"],"chEBI":["4453"]},"count":4,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["MP_0001914","EFO_0010269","EFO_0000545","EFO_0000731","Orphanet_661","EFO_0003894","EFO_0000660"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 investigational indications."}
{"id":"CHEMBL153984","canonicalSmiles":"CC(=O)c1cc2cccc(OCC(O)CNC(C)C)c2o1","inchiKey":"ZPQPDBIHYCBNIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEFUNOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Befunolol","Befunolol hydrochloride"],"crossReferences":{"Wikipedia":["Befunolol"],"drugbank":["DB09013"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1560089","canonicalSmiles":"CN(CCO)CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C.O=C(O)c1cccnc1","inchiKey":"GEPMAHVDJHFBJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANTHINOL NIACINATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1624126","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Complamin","Complamin ret"],"synonyms":["Xanthinol niacinate","Xanthinol nicotinate","Xantinol nicotinate"],"crossReferences":{"PubChem":["104171397","144204417","26757854","855806"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL15797","canonicalSmiles":"c1cnccn1","inchiKey":"KYQCOXFCLRTKLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRAZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 4015","NSC-400221","Pyrazine"],"crossReferences":{"PubChem":["144210109"],"Wikipedia":["Pyrazine"],"chEBI":["30953"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1614713","canonicalSmiles":"c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1","inchiKey":"XDJCLCLBSGGNKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CC-401","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-401","Cc-401"],"crossReferences":{"drugbank":["DB12432"]},"count":1,"linkedTargets":{"rows":["ENSG00000107643","ENSG00000050748","ENSG00000109339"],"count":3},"linkedDiseases":{"rows":["MONDO_0004643"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1614766","canonicalSmiles":"O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F","inchiKey":"FIMYFEGKMOCQKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RO-4987655","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CH-4987655","RO4987655","Ro 4987655","Ro-4987655"],"crossReferences":{"drugbank":["DB12933"]},"count":1,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1615371","canonicalSmiles":"CN1c2c([nH]c(N)nc2=O)NC[C@@H]1CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1.[Ca+2]","inchiKey":"VWBBRFHSPXRJQD-QNTKWALQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEFOLATE CALCIUM","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1231574","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bodyfolin","Metafolin","Nutrifolin"],"synonyms":["Calcium levomefolate","LMC-A","LMCA","Levomefolate calcium","NDI 638"],"crossReferences":{"DailyMed":["levomefolate%20calcium"]},"count":2,"approvedIndications":["EFO_0003894","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for acne and iron deficiency anemia."}
{"id":"CHEMBL1686","canonicalSmiles":"O=C(O)CCC(=O)C(=O)O","inchiKey":"KPGXRSRHYNQIFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHA-KETOGLUTARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxoglutarate","2-Oxopentanedioic Acid","Alpha-Ketoglutarate"],"crossReferences":{"PubChem":["144208116","17389187","80706"],"Wikipedia":["Alpha-Ketoglutaric_acid"],"drugbank":["DB08845"],"chEBI":["30915"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697739","canonicalSmiles":"CCC(C(=O)O)C1(O)CCCCC1","inchiKey":"NIVFTEMPSCMWDE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBUTYROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclobutyrol"],"crossReferences":{"drugbank":["DB13493"],"chEBI":["61024"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL170","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12","inchiKey":"LOUPRKONTZGTKE-WZBLMQSHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUININE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-192949","Quinine","WR297608"],"crossReferences":{"DailyMed":["quinine%20sulfate"],"Wikipedia":["Quinine"],"drugbank":["DB00468"],"chEBI":["15854"]},"childChemblIds":["CHEMBL3707252","CHEMBL1201100","CHEMBL2146105","CHEMBL3707329","CHEMBL2146083","CHEMBL588046","CHEMBL3229759","CHEMBL3229764","CHEMBL589001","CHEMBL1899143","CHEMBL2146084","CHEMBL2359966","CHEMBL2146088","CHEMBL3707332","CHEMBL3706390"],"count":3,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for malaria and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL17157","canonicalSmiles":"CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1","inchiKey":"GUGOEEXESWIERI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERFENADINE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," France"," Oman"," Saudi Arabia"],"classes":["Cardiotoxicity"],"year":1998},"tradeNames":["Antihistamine","Histafen","Histafen 120","Seldane","Terfenor","Terfenor fte","Terfex","Terfinax 120","Terfinax 60","Triludan","Triludan fte"],"synonyms":["RMI 9918","RMI-9918","Terfenadine"],"crossReferences":{"PubChem":["104171258","144203846","144203847","170465598","26752308","50105228","56422373","85231279","855647","90341346"],"Wikipedia":["Terfenadine"],"drugbank":["DB00342"],"chEBI":["9453"]},"count":6,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0003840","EFO_0000270","EFO_0000403","EFO_0004197","EFO_0007304","EFO_0003785"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for allergy and has 5 investigational indications. It was withdrawn in United States,  France,  Oman and  Saudi Arabia initially in 1998 due to Cardiotoxicity."}
{"id":"CHEMBL1739","canonicalSmiles":"COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3.[I-].[I-]","inchiKey":"DIGFQJFCDPKEPF-OIUSMDOTSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"METOCURINE IODIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1259","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metubine iodide"],"synonyms":["Dimethyl tubocurarine iodide","Metocurine iodide"],"crossReferences":{"PubChem":["144206308","170465111"],"drugbank":["DB00416"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1742983","drugType":"Antibody","blackBoxWarning":false,"name":"ALACIZUMAB PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alacizumab pegol","CDP-791","g165 DFM-PEG"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1743024","drugType":"Antibody","blackBoxWarning":false,"name":"GANITUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 479","AMG-479","AMG479","Ganitumab"],"count":11,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_1001480","EFO_1000044","EFO_0003893","EFO_0003968","EFO_0000174","MONDO_0007254","EFO_0000702","EFO_0002918","EFO_0000691","EFO_0003060","EFO_0000311"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL1743030","drugType":"Antibody","blackBoxWarning":false,"name":"ICRUCUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC 18F1","IMC-18F1","IMC18F1","Icrucumab"],"count":4,"linkedTargets":{"rows":["ENSG00000102755"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000657","MONDO_0007254","MONDO_0021063"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1743038","drugType":"Antibody","blackBoxWarning":false,"name":"LUCATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-12.12","HCD-122","HCD122","Lucatumumab"],"count":5,"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0001378","EFO_0000183","MONDO_0018906","EFO_0005952"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1752","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O","inchiKey":"KSCFJBIXMNOVSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DYPHYLLINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dilor","Dilor-400","Lufyllin","Neothylline"],"synonyms":["Diprophylline","Dyphylline","Glyphylline"],"crossReferences":{"PubChem":["144203995","170465316","174006928","56422180","855557"],"Wikipedia":["Dyphylline"],"drugbank":["DB00651"],"chEBI":["4728"]},"count":1,"approvedIndications":["HP_0006536"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000172572","ENSG00000184588"],"count":5},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951 and is indicated for airway obstruction."}
{"id":"CHEMBL175691","canonicalSmiles":"Cc1cc(/C=C/C#N)cc(C)c1Nc1ccnc(Nc2ccc(C#N)cc2)n1","inchiKey":"YIBOMRUWOWDFLG-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILPIVIRINE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edurant"],"synonyms":["R 278474","R-278474","Rilpivirine","TMC-278","TMC278"],"crossReferences":{"DailyMed":["rilpivirine%20hydrochloride"],"Wikipedia":["Rilpivirine"],"drugbank":["DB08864"],"chEBI":["68606"]},"childChemblIds":["CHEMBL1628504"],"count":6,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for viral disease and has 5 investigational indications."}
{"id":"CHEMBL1773683","canonicalSmiles":"CCS(=O)(=O)c1ccc2oc(-c3ccc4ccccc4c3)nc2c1","inchiKey":"KSGCNXAZROJSNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZUTROMID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN 195","BMN-195","Ezutromid","SMT-C1100","SMTC-1100","Smt c1100"],"crossReferences":{"drugbank":["DB12888"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1788400","canonicalSmiles":"O=C(C(Cl)Cl)N(CCO)Cc1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1","inchiKey":"ODCUSWJXZDHLKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEFAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorophenoxamide","Clefamide"],"crossReferences":{"drugbank":["DB13512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180948","canonicalSmiles":"CC(C)C[C@@]1(C(=O)O)C[C@H](C(=O)O)[C@H](c2cccs2)N1C(=O)c1ccc(C(F)(F)F)cc1","inchiKey":"ZNCZVHCYBGHCHA-XPIZARPCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1823518","canonicalSmiles":"CCOC(=O)[C@H](C)NP(=O)(COCCn1cnc2c(NC3CC3)nc(N)nc21)N[C@@H](C)C(=O)OCC","inchiKey":"ANSPEDQTHURSFQ-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RABACFOSADINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9219","Rabacfosadine","VDC-1101"],"crossReferences":{"drugbank":["DB12762"]},"childChemblIds":["CHEMBL3137324"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1836264","canonicalSmiles":"O=c1oc2cc(O)ccc2c2ccc(O)cc12","inchiKey":"RIUPLDUFZCXCHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1836264","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15464"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190083","canonicalSmiles":"C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"SYTBZMRGLBWNTM-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARENFLURBIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Flurizan"],"synonyms":["E-7869","MPC-7869","Tarenflurbil"],"crossReferences":{"PubChem":["11112562","11114208","520769","520770"],"drugbank":["DB05289"],"chEBI":["38666"]},"count":3,"linkedTargets":{"rows":["ENSG00000205155","ENSG00000138613","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["HP_0000726","EFO_0000249","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1908376","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)/C=C/C=C/C(O)(CC)CC)C[C@@H](O)C[C@@H]1O","inchiKey":"LVLLALCJVJNGQQ-SEODYNFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEOCALCITOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-1089","Eb-1089","Seocalcitol"],"crossReferences":{"drugbank":["DB04258"]},"count":1,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000182"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1908394","canonicalSmiles":"C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F","inchiKey":"ZHJGWYRLJUCMRT-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-461364","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-461364A","Gsk 461364","Gsk-461364"],"count":1,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1922106","canonicalSmiles":"Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12.Cl","inchiKey":"YHXCPNAVNKJANM-RSAXXLAASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1922106","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1922094","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL19299","canonicalSmiles":"CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1","inchiKey":"YMBXTVYHTMGZDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOXOPROFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loxoprofen","Loxoprofen sodium"],"crossReferences":{"PubChem":["144203729","170465808","50106490","85231106","90341428"],"Wikipedia":["Loxoprofen"],"drugbank":["DB09212"],"chEBI":["76172"]},"childChemblIds":["CHEMBL66552"],"count":5,"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0002970","EFO_0000685","HP_0030833","EFO_0003898","HP_0003419","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1950045","canonicalSmiles":"OCCc1ccc(O)c(O)c1","inchiKey":"JUUBCHWRXWPFFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-Dihydroxyphenylethanol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dihydroxyphenylethanol"],"crossReferences":{"drugbank":["DB12771"],"chEBI":["68889"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL196228","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@H]2O","inchiKey":"MUMGGOZAMZWBJJ-KZYORJDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPITESTOSTERONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitestosterone"],"crossReferences":{"PubChem":["144204609"],"Wikipedia":["Epitestosterone"],"drugbank":["DB07768"],"chEBI":["42534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2018096","canonicalSmiles":"OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"AHFWIQIYAXSLBA-RQXATKFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRAGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1941","Ipragliflozin"],"crossReferences":{"drugbank":["DB11698"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2059028","canonicalSmiles":"COc1cc(C(=O)C(=O)N(C)[C@@H](Cc2ccc(Cl)cc2)C(=O)N(Cc2ccccc2)C(CCc2ccncc2)CCc2ccncc2)cc(OC)c1OC","inchiKey":"MQSMWZHHUGSULF-QNGWXLTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMCODAR","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Timcodar","VX-853","Vx-853"],"crossReferences":{"drugbank":["DB12761"]},"childChemblIds":["CHEMBL3989889"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2062261","canonicalSmiles":"CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O=C(O)C(O)C(O)C(=O)O","inchiKey":"RWTWIZDKEIWLKQ-DYWKTHLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVORPHANOL TARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL592","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Levo-Dromoran","Levorphanol Tartrate"],"synonyms":["Levorphanol tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096625","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O=S(=O)(O)O","inchiKey":"USAHOPJHPJHUNS-IFCNUISUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL70","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"chEBI":["7003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103807","canonicalSmiles":"CC(C)Cn1cnc2c(N)nc3cccnc3c21","inchiKey":"UCPMSMNKGXUFCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPETIRIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["851-A","851A","Epetirimod","S-30563"],"childChemblIds":["CHEMBL2103808"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105011","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C[131I])[C@H]3CC[C@@]21C","inchiKey":"FIOAEFCJGZJUPW-ODFYUTSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOCHOLESTEROL I 131","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110675","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iodocholesterol (131i)","Iodocholesterol i 131"],"crossReferences":{"drugbank":["DB13797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105051","canonicalSmiles":"Clc1cnn(CCCCN2CCN(c3ncccn3)CC2)c1","inchiKey":"AHCPKWJUALHOPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LESOPITRON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lesopitron"],"crossReferences":{"drugbank":["DB04970"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105338","canonicalSmiles":"CCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O","inchiKey":"MRWQRJMESRRJJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTIFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pentifylline"],"crossReferences":{"PubChem":["170466365"],"drugbank":["DB13634"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105753","canonicalSmiles":"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C.Cl","inchiKey":"PKVZBNCYEICAQP-GSTSRXQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMECAMYLAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2103881","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexmecamylamine hydrochloride","NIH-11008","TC-5214"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106370","canonicalSmiles":"COc1ccnc(C[S+]([O-])c2nc3cc(-n4cccc4)ccc3[nH]2)c1C","inchiKey":"HRRXCXABAPSOCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILAPRAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ilaprazole"],"crossReferences":{"drugbank":["DB11964"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2106669","canonicalSmiles":"C[C@H](N)Cc1ccccc1.O=P(O)(O)O","inchiKey":"ZHVLGOLHHYJSBZ-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROAMPHETAMINE PHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL612","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dextroamphetamine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107823","canonicalSmiles":"Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1","inchiKey":"SQSZANZGUXWJEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANDOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gandotinib","LY-2784544","LY2784544","Ly-2784544","Ly2784544"],"crossReferences":{"drugbank":["DB13040"]},"count":1,"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107857","drugType":"Protein","blackBoxWarning":true,"name":"METRELEPTIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Metreleptin","R-METHULEPTIN"],"crossReferences":{"DailyMed":["metreleptin"],"DrugCentral":["4826"]},"count":8,"approvedIndications":["EFO_1000727"],"linkedTargets":{"rows":["ENSG00000116678"],"count":1},"linkedDiseases":{"rows":["EFO_0000195","EFO_0010269","MONDO_0027766","EFO_0003095","EFO_0002614","EFO_0001359","EFO_1001348","EFO_0001073","EFO_1000727","EFO_0002756","Orphanet_98306"],"count":11},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for lipodystrophy and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107991","drugType":"Unknown","blackBoxWarning":false,"name":"GELATIN SPONGE, ABSORBABLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Spongostan","Sterispon"],"synonyms":["Absorbable gelatin sponge","Gelatin sponge, absorbable"],"count":1,"approvedIndications":["MP_0001914"],"description":"Unknown drug with a maximum clinical trial phase of IV and is indicated for hemorrhage."}
{"id":"CHEMBL2108597","drugType":"Unknown","blackBoxWarning":false,"name":"FERRIC CARBOXYMALTOSE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Injectafer"],"synonyms":["Ferric carboxymaltose","VIT-45"],"crossReferences":{"DailyMed":["ferric%20carboxymaltose"],"DrugCentral":["5128"]},"count":8,"approvedIndications":["HP_0001891"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for iron deficiency anemia and has 7 investigational indications."}
{"id":"CHEMBL2109093","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN DELTA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynepo","Dynepo (pending)"],"synonyms":["Epoetin delta","GA-EPO","HMR-4396","HMR4396"],"description":"Protein drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109151","drugType":"Antibody","blackBoxWarning":false,"name":"LUMILIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gomiliximab","IDEC-152","Lumiliximab","P5E8 SI-3401 GOMILIXIMAB","ST-152"],"count":3,"linkedTargets":{"rows":["ENSG00000104921"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000095","EFO_0000574"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109312","drugType":"Antibody","blackBoxWarning":false,"name":"MK-3415","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actoxumab","MDX-066","MK-3415","Mk-3415"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109406","drugType":"Antibody","blackBoxWarning":false,"name":"PATRITUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Patritumab"],"count":6,"linkedTargets":{"rows":["ENSG00000065361"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003968","EFO_0004284","MONDO_0007254","EFO_0003060","EFO_0000181"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109463","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-679586A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-679586A","Gsk-679586a"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2140408","canonicalSmiles":"Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1","inchiKey":"IVUGFMLRJOCGAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-900","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-900","AMG900","Amg 900","Amg-900"],"crossReferences":{"PubChem":["137275938"]},"count":2,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["MONDO_0004643","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2146140","canonicalSmiles":"COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.O.O.O.O.[Sr+2]","inchiKey":"NCGHIAKEJNQSMS-QLGOZJDFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE STRONTIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201320","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esomeprazole strontium"],"synonyms":["Esomeprazole strontium","FM0F67"],"crossReferences":{"DailyMed":["esomeprazole%20strontium"]},"count":4,"approvedIndications":["EFO_0003948","EFO_0009454","EFO_0004607","EFO_0007549"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0009454","EFO_0004607","EFO_0007549"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved indications."}
{"id":"CHEMBL2178570","canonicalSmiles":"CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1","inchiKey":"RKWKLTLIBREDHD-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD4818","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4818","AZD4818","Azd 4818","Azd4818"],"count":1,"linkedTargets":{"rows":["ENSG00000163823"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2216859","canonicalSmiles":"CC(C)N1CCN(Cc2cnc(-c3cc(-c4cccc5[nH]ccc45)cc4[nH]ncc34)o2)CC1","inchiKey":"MCIDWGZGWVSZMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEMIRALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2269557","GSK-2269557 FREE BASE","GSK-2269557A","GSK2269557A","Nemiralisib"],"childChemblIds":["CHEMBL4297193"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2218896","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)C1CCC(=O)CC21","inchiKey":"GECBBEABIDMGGL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NABILONE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cesamet"],"synonyms":["CPD 109514","CPD-109514","Nabilone"],"crossReferences":{"DailyMed":["nabilone"]},"count":9,"approvedIndications":["HP_0002018"],"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0001257","EFO_0003885","EFO_1000783","EFO_0007191","EFO_0005687","HP_0009763","EFO_0002508","EFO_0003100","HP_0002017","EFO_0004888","EFO_0004242","HP_0002018"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for nausea and has 8 investigational indications."}
{"id":"CHEMBL2364632","canonicalSmiles":"CON(C)Cc1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"PQJQFLNBMSCUSH-SBAJWEJLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARECYCLINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["P-005672","P005672","Sarecycline"],"crossReferences":{"DailyMed":["sarecycline%20hydrochloride"],"drugbank":["DB12035"]},"childChemblIds":["CHEMBL2364633"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL2369994","canonicalSmiles":"CC(=O)NCSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@H](C(=O)N[C@@H](CSCNC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O.O=C(O)C(F)(F)F","inchiKey":"PNJSAKBBGRRTHL-RBUYSXEJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TIGAPOTIDE TRIFLUTATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL3040192","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PCK3145","Tigapotide triflutate"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2396989","canonicalSmiles":"NC1=N[C@@]2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COC[C@H]2CS1","inchiKey":"NIDRNVHMMDAAIK-YPMLDQLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2886721","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2886721","Ly-2886721","Ly2886721"],"crossReferences":{"drugbank":["DB12547"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL253363","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"ORNBQBCIOKFOEO-QGVNFLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREGNENOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pregnenolone"],"crossReferences":{"PubChem":["144205564","144212458","170465558","26756472","29216415","56463239"],"Wikipedia":["Pregnenolone"],"drugbank":["DB02789"],"chEBI":["16581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL257543","canonicalSmiles":"N#Cc1ccc(NCC(F)(F)c2ccccn2)c(F)c1CC(=O)NCCONC(=N)N","inchiKey":"STHCHQXQLDMISY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257543","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07665"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282042","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O","inchiKey":"IRHXGOXEBNJUSN-YOXDLBRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAQUINAVIR MESYLATE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL114","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortovase","Invirase"],"synonyms":["RO 31-8959/003","RO-318959003","Ro-31-8959-003","Saquinavir mesilate","Saquinavir mesylate","Saquinavir methanesulfonate salt"],"crossReferences":{"DailyMed":["saquinavir%20mesylate"],"PubChem":["144204688","144209731","17388741","49681831"],"chEBI":["32121"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 2 investigational indications."}
{"id":"CHEMBL282199","canonicalSmiles":"CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1","inchiKey":"HWKROQUZSKPIKQ-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-269970","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-269970"],"crossReferences":{"PubChem":["11114150","50104910"],"Wikipedia":["SB-269,970"],"drugbank":["DB13988"]},"childChemblIds":["CHEMBL1256844"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284121","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@]3(C)C([C@H](C)CC#CC(C)(C)O)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O","inchiKey":"JKFZMIQMKFWJAY-RQJQXFIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ILX23-7553","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BXL 353","ILX7553","Ilx23-7553","Ro-23-7553"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296913","canonicalSmiles":"CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+]","inchiKey":"HQPVVKXJNZEAFW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PARECOXIB SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1206690","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dynastat"],"synonyms":["Parecoxib sodium","Parecoxib sodium salt","SC-69124A"],"crossReferences":{"PubChem":["144206591"]},"count":2,"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_0003843","EFO_1000635"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL299155","canonicalSmiles":"O=C(O)c1cc(=O)c2ccccc2[nH]1","inchiKey":"HCZHHEIFKROPDY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANSTORINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kynurenic Acid","Transtorine"],"crossReferences":{"PubChem":["11111352","11113415","124880498","124880499","26747099","26747100","26751656","50104346","50104347","50104348","56463252","85231101","90340624"],"Wikipedia":["Kynurenic_acid"],"drugbank":["DB11937"],"chEBI":["18344"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3121849","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc3cc(-c4ccc5nc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]c5c4)ccc3c2)[nH]1)C(C)C","inchiKey":"LCHMHYPWGWYXEL-ZYADHFCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVIDASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 238630","BI-238630","C5","PPI-668 free base","Ravidasvir"],"crossReferences":{"drugbank":["DB15652"]},"childChemblIds":["CHEMBL3545312"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL316632","canonicalSmiles":"C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CCc1ccccc1","inchiKey":"ZQHYKVKNPWDQSL-KNXBSLHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL316632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13606"],"chEBI":["8056"]},"childChemblIds":["CHEMBL2358977"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3183075","canonicalSmiles":"CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1","inchiKey":"SGXXNSQHWDMGGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIZATIDINE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Axid","Axid ar","Nizatidine","Zinga 150","Zinga 300"],"synonyms":["LY 139037","LY-139037","Nizatidine"],"crossReferences":{"DailyMed":["nizatidine"],"PubChem":["144204242","144211911","170464780"],"drugbank":["DB00585"],"chEBI":["7601"]},"count":4,"approvedIndications":["HP_0004398","EFO_0003948"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398","EFO_0000217","EFO_1000948","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for peptic ulcer and gastroesophageal reflux disease and has 2 investigational indications."}
{"id":"CHEMBL3184512","canonicalSmiles":"CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)N(C)C1","inchiKey":"UFUVLHLTWXBHGZ-MGZQPHGTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN PHOSPHATE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleocin","Cleocin phosphate","Cleocin t","Clinda-derm","Clindagel","Clindamycin phosphate","Clindesse","Clindets","Dalacin","Dalacin c phos","Dalacin t","Evoclin","Zindaclin"],"synonyms":["Clindamycin 2-dihydrogen phosphate","Clindamycin phosphate","NSC-618653","U 28508","U-28,508","U-28508"],"crossReferences":{"DailyMed":["clindamycin%20phosphate"],"PubChem":["144206606","144206960"]},"count":16,"approvedIndications":["EFO_0003106","HP_0100806","EFO_1001084","EFO_0008588","EFO_0003097","EFO_0000544","EFO_1001362","EFO_1001753","EFO_0003030","EFO_0003102","EFO_1001312","EFO_0003894","EFO_0009549"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 13 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3185236","canonicalSmiles":"COc1ncc(F)c2nc(S(=O)(=O)Nc3c(F)cccc3F)nn12","inchiKey":"QZXATCCPQKOEIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORASULAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212750"],"drugbank":["DB15316"],"chEBI":["82009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3185709","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"DSZOEVVLZMNAEH-BXUJZNQYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL3185709","maximumClinicalTrialPhase":0,"parentId":"CHEMBL395429","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205892"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186751","canonicalSmiles":"CCOc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1","inchiKey":"FFJIWWBSBCOKLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186751","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206640"],"drugbank":["DB11462"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3248963","canonicalSmiles":"Cl.NC[C@H](O)c1ccc(O)c(O)c1","inchiKey":"FQTFHMSZCSUVEU-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3248963","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325795","canonicalSmiles":"COc1ccc([C@H]2CNC(=O)C2)cc1OC1CCCC1","inchiKey":"HJORMJIFDVBMOB-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-ROLIPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-(+)-Rolipram"],"crossReferences":{"drugbank":["DB03606"],"chEBI":["59540"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328875","canonicalSmiles":"NCc1ccc(C(=O)O)cc1","inchiKey":"QCTBMLYLENLHLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOMETHYLBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-(Aminomethyl)Benzoic Acid","4-Aminomethyl-Benzoic Acid","Aminomethylbenzoic acid"],"crossReferences":{"PubChem":["4252934","96420"],"Wikipedia":["Aminomethylbenzoic_acid"],"drugbank":["DB13244"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3298910","canonicalSmiles":"CCc1nc2ccc(Cl)cn2c1C(=O)NCc1ccc(N2CCC(c3ccc(OC(F)(F)F)cc3)CC2)cc1","inchiKey":"OJICYBSWSZGRFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELACEBEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Q-203","Q203","Telacebec"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301572","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"NUSINERSEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BIIB-058","BIIB058","ISIS 396443","ISIS-396443","Nusinersen"],"crossReferences":{"DrugCentral":["5207"]},"count":1,"linkedTargets":{"rows":["ENSG00000205571"],"count":1},"linkedDiseases":{"rows":["EFO_0008525"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3301595","canonicalSmiles":"N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21","inchiKey":"SRPXSILJHWNFMK-MEDUHNTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASOTRALINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dasotraline","SEP-225289"],"crossReferences":{"drugbank":["DB12305"]},"childChemblIds":["CHEMBL3301596"],"count":3,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","MONDO_0002009"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL33845","canonicalSmiles":"Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O","inchiKey":"MDNWOSOZYLHTCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICHLOROPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dichlorophen","G-4"],"crossReferences":{"PubChem":["144204663","144208627","144213330","170465475","17389622","26747332","26747333","26752973","50105570","56422874","8139897"],"Wikipedia":["Dichlorophene"],"drugbank":["DB11396"],"chEBI":["34689"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL349605","canonicalSmiles":"OC[C@H](O)[C@H](O)CO","inchiKey":"UNXHWFMMPAWVPI-ZXZARUISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E968","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E968"],"crossReferences":{"PubChem":["144207762","57260106"],"Wikipedia":["Erythritol"],"drugbank":["DB04481"],"chEBI":["17113"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL35","canonicalSmiles":"NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl","inchiKey":"ZZUFCTLCJUWOSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FUROSEMIDE","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aluzine 20","Aluzine 40","Aluzine 500","Aquamed","Disal","Diuresal","Dryptal","Froop","Frumax","Frumil","Frusemide","Frusetic","Frusid","Frusol","Furosemide","Hydroled","Lasix","Lasix ret","Rusyde","Tenkofruse"],"synonyms":["Frusemide","Furosemide","LB-502","NSC-269420"],"crossReferences":{"DailyMed":["furosemide"],"PubChem":["11112125","144203873","144209411","144213288","170464879","17389872","47193739"],"TG-GATEs":["78"],"Wikipedia":["Furosemide"],"drugbank":["DB00695"],"chEBI":["47426"]},"childChemblIds":["CHEMBL1788133"],"count":29,"approvedIndications":["EFO_0001422","EFO_0003144","EFO_0004255","EFO_0000373","EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000074803"],"count":1},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003086","EFO_0000401","EFO_0009373","EFO_0000373","EFO_0009840","EFO_1002048","HP_0011950","EFO_0000565","EFO_0003914","Orphanet_70589","EFO_0003144","EFO_0003884","EFO_0004255","EFO_1002032","EFO_0003917","EFO_0000400","EFO_0000692","MONDO_0024664","HP_0002094","HP_0003124","HP_0001919","EFO_0001645","EFO_0000222","EFO_0000319","EFO_0003818","EFO_0002496","EFO_0000537","EFO_0000311","EFO_0001422","EFO_1000391","EFO_0009662","EFO_0003827","EFO_0008583","EFO_0001360","EFO_0000668","EFO_1000899"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and has 6 approved and 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL35084","canonicalSmiles":"COCCOC[C@H](CC1(C(=O)N[C@H]2CC[C@@H](C(=O)O)CC2)CCCC1)C(=O)Oc1ccc2c(c1)CCC2","inchiKey":"ZTWZVMIYIIVABD-OEMFJLHTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDOXATRIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Candoxatril","UK-79,300"],"crossReferences":{"PubChem":["144210768"],"drugbank":["DB00616"],"chEBI":["3353"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3542235","canonicalSmiles":"CN(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)[C@H](c1ccccc1)N1CCN(CC2CC2)CC1.Cl.O","inchiKey":"DBRLJEGCBBXRQN-ASMAMLKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542235","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2104927","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3542362","canonicalSmiles":"Nc1nc(CC(=O)N[14c]2[14cH][14cH][14c](CCNC[C@H](O)c3ccccc3)[14cH][14cH]2)cs1","inchiKey":"PBAPPPCECJKMCM-NDAYHVAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542362","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2095212","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544988","canonicalSmiles":"O=C(O)CNC(=O)C1C(=O)N(C2CCCCC2)C(=O)N(C2CCCCC2)C1=O","inchiKey":"RUEYEZADQJCKGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPRODUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Daprodustat","GSK-1278863","GSK1278863"],"crossReferences":{"drugbank":["DB11682"]},"count":3,"linkedTargets":{"rows":["ENSG00000135766","ENSG00000178467","ENSG00000129521","ENSG00000269858"],"count":4},"linkedDiseases":{"rows":["EFO_0000546","EFO_0003875","EFO_0004272"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545050","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-817378","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-817378"],"count":1,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545113","drugType":"Small molecule","blackBoxWarning":false,"name":"PX-102","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Px-102","Px-104"],"count":1,"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_0003095"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545141","drugType":"Small molecule","blackBoxWarning":false,"name":"RP-6530","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rp-6530"],"count":2,"linkedTargets":{"rows":["ENSG00000171608","ENSG00000105851"],"count":2},"linkedDiseases":{"rows":["EFO_0002913","EFO_0000574"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545200","drugType":"Small molecule","blackBoxWarning":false,"name":"S-222611","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-222611"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545259","drugType":"Antibody","blackBoxWarning":false,"name":"VANUCIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7221","RG7221","RO-5520985","RO5520985","Vanucizumab"],"count":2,"linkedTargets":{"rows":["ENSG00000091879","ENSG00000112715"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545354","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFUSERTIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cafusertib"],"count":2,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545386","drugType":"Small molecule","blackBoxWarning":false,"name":"BI113823","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bi113823"],"count":1,"linkedTargets":{"rows":["ENSG00000100739"],"count":1},"linkedDiseases":{"rows":["EFO_0002506"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3646118","canonicalSmiles":"O=c1c(-n2ccnn2)c[nH]n1-c1cc(N2CCOCC2)ncn1","inchiKey":"IJMBOKOTALXLKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3646118","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3702854","canonicalSmiles":"CC(C)(/C=C(\\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1","inchiKey":"LCFFREMLXLZNHE-GBOLQPHISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILZABRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRN1008","Prn1008","Rilzabrutinib"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707260","canonicalSmiles":"Nc1nc(O)c2c(n1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Na+].[Na+]","inchiKey":"FSDMNNPYPVJNAT-RIWFDJIXSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM FOLINATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1679","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium folinate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707315","drugType":"Small molecule","blackBoxWarning":false,"name":"D-3263","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D 3263","D-3263","D-3263 (FREE BASE)"],"count":1,"linkedTargets":{"rows":["ENSG00000144481"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707389","canonicalSmiles":"NC(CCCN1C(=O)NC(c2ccccc2)(c2ccccc2)C1=O)C(=O)O","inchiKey":"PAJBBDCZSMDSFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINO(DIPHENYLHYDANTOIN) VALERIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amino(diphenylhydantoin) valeric acid"],"crossReferences":{"drugbank":["DB13396"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL375971","canonicalSmiles":"CN(C)c1ccc(/N=N/c2ccccc2C(=O)O)cc1","inchiKey":"CEQFOVLGLXCDCX-WUKNDPDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-((4-(Dimethylamino)Phenyl)Diazenyl)Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-((4-(Dimethylamino)Phenyl)Diazenyl)Benzoic Acid"],"crossReferences":{"PubChem":["124898747","144211653"],"drugbank":["DB08209"],"chEBI":["49770"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833339","canonicalSmiles":"CC(C)CCON=O.CCC(C)CON=O","inchiKey":"XNCKCDBPEMSUFA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMYL NITRITE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amyl nitrite"],"crossReferences":{"DrugCentral":["205"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3833375","canonicalSmiles":"O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]B1OB2OB([O-])OB(O1)O2","inchiKey":"CDMADVZSLOHIFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BORATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3833411","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium borate"],"crossReferences":{"DrugCentral":["4795"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL383990","canonicalSmiles":"c1ccc2[nH]c(-c3n[nH]c4ccccc34)nc2c1","inchiKey":"JTKFRFMSUBOCIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383990","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL387262","canonicalSmiles":"N=C(N)NC(=N)SCc1cccc(C(F)(F)F)c1","inchiKey":"DWJNPCRXBNWCJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(3-Trifluoromethylphenyl)Methylamidinoisothiourea","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(3-Trifluoromethylphenyl)Methylamidinoisothiourea"],"crossReferences":{"drugbank":["DB07262"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3895543","canonicalSmiles":"NC(=O)c1cccc([C@@H]2C[C@@H]3CC[C@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1.O=C(O)C(=O)O","inchiKey":"ROTSIYXENLBTJT-WTKDUOFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3895543","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3137313","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3936761","canonicalSmiles":"C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1","inchiKey":"RNOAOAWBMHREKO-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANUBRUTINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brukinsa"],"synonyms":["BGB-3111","Bgb-3111","Zanubrutinib"],"crossReferences":{"DailyMed":["zanubrutinib"],"drugbank":["DB15035"]},"count":9,"approvedIndications":["EFO_1001469"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000565","EFO_0005761","MONDO_0100096","EFO_0000096","EFO_0000095","MONDO_0017287","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_1001469","MONDO_0002083","EFO_0000311"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for mantle cell lymphoma and has 8 investigational indications."}
{"id":"CHEMBL3989402","canonicalSmiles":"CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N.O.O.O","inchiKey":"RFUCJKFZFXNIGB-ZBBHRWOZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERAMIVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139367","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rapivab"],"synonyms":["BCX-1812","Peramivir"],"count":1,"approvedIndications":["EFO_0007328"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for influenza."}
{"id":"CHEMBL3989945","canonicalSmiles":"CCCCCOc1ccc(-c2ccc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](OCC[N+](C)(C)C)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1","inchiKey":"LNFCWEXGZIEGJW-TXSVMFMRSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"REZAFUNGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD-101","CD101","Rezafungin","SP-3025"],"childChemblIds":["CHEMBL3989928"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3991065","canonicalSmiles":"C[C@@H]1[C@H](c2c(F)ccc(F)c2F)C[C@H](NC(=O)c2cnc3c(c2)C[C@@]2(C3)C(=O)Nc3ncccc32)C(=O)N1CC(F)(F)F","inchiKey":"QIVUCLWGARAQIO-OLIXTKCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATOGEPANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-241689","Atogepant","MK-8031"],"childChemblIds":["CHEMBL3981883"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL402315","canonicalSmiles":"C[C@H]1C[C@@H](C)CN(C(=O)c2cc(Br)ccc2NC(=O)CCC(=O)N2CCOCC2)C1","inchiKey":"DELARNBPJXTDBD-IYBDPMFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL402315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL409","canonicalSmiles":"CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1","inchiKey":"LKJPYSCBVHEWIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BICALUTAMIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bicalutamide","Calutide","Casodex","Cosudex","Kalumid"],"synonyms":["Bicalutamide","Casodex","ICI 176,334","ICI-176334","ICI176,334-1"],"crossReferences":{"DailyMed":["bicalutamide"],"PubChem":["26719836"],"drugbank":["DB01128"]},"count":14,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","EFO_0000616","EFO_0003869","MONDO_0008170","MONDO_0007254","MONDO_0004669","MONDO_0002087","EFO_0000305","MONDO_0008315","HP_0000771","EFO_0001663","MONDO_0002158","MONDO_0100096","MONDO_0000088","EFO_0000196","EFO_0000673"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for neoplasm and has 13 investigational indications."}
{"id":"CHEMBL410668","canonicalSmiles":"CNC(=O)c1ccc(C)c(Nc2ncnc3c2cnn3-c2ccccc2)c1","inchiKey":"OYTBZXSFNNAVKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL410668","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08242"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL425646","canonicalSmiles":"N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12","inchiKey":"NHBIWLQQJPSMNP-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL425646","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08087"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297308","canonicalSmiles":"CC(C)C[C@@H](NC(=O)[C@H](NC(=O)[C@@H](CO)NC(=O)[C@H]1CCCN1C(=O)[C@@H](CC(C)C)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)Cc1c[nH]c2ccccc12)C(C)O)C(C)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)O","inchiKey":"FNQVICDIQNFNHD-NBFSZNPRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NEROFE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nerofe"],"count":3,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297520","canonicalSmiles":"CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1","inchiKey":"OKFDRAHPFKMAJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OGLEMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GRC 3845","Oglemilast"],"crossReferences":{"drugbank":["DB12375"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297550","drugType":"Unknown","blackBoxWarning":false,"name":"ATYR-1940","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atyr-1940","Atyr1940"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297569","drugType":"Unknown","blackBoxWarning":false,"name":"AVIDIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avidin"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297641","canonicalSmiles":"C/C(=N\\NC(=O)c1cccc(S(=O)(=O)N2CCN(C)CC2)c1)c1cc(Cl)ccc1O","inchiKey":"MVSQDUZRRVBYLA-HYARGMPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SECLIDEMSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SP-2577","SP2577","Seclidemstat","Sp-2577"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297646","canonicalSmiles":"Fc1cc(F)c(OCc2ccccc2C2CCNCC2)c(F)c1","inchiKey":"TZIALEBTHQWNAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMPRELOXETINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ampreloxetine","TD-9855","Td-9855"],"crossReferences":{"drugbank":["DB15348"]},"childChemblIds":["CHEMBL4594277"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297801","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGUNIGALSIDASE ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PRX-102","Pegunigalsidase alfa","Prx-102"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297838","drugType":"Unknown","blackBoxWarning":false,"name":"TILSOTOLIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMO-2125","Tilsotolimod"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297976","drugType":"Enzyme","blackBoxWarning":false,"name":"N-SULFOGLUCOSAMINE SULFOHYDROLASE RECOMBINANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HGT-1410","Hgt-1410","N-sulfoglucosamine sulfohydrolase recombinant"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297989","drugType":"Protein","blackBoxWarning":false,"name":"INTERLEUKIN 15, RECOMBINANT NON-GLYCOSYLATED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Il-15","Interleukin 15, recombinant non-glycosylated"],"count":4,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4298080","drugType":"Unknown","blackBoxWarning":false,"name":"COAGULATION FACTOR IX RECOMBINANT HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coagulation factor ix recombinant human","Nonacog alfa","Nonacog gamma","Recombinant factor ix"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298101","drugType":"Antibody","blackBoxWarning":false,"name":"LADIRATUZUMAB VEDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ladiratuzumab vedotin","SGN-LIV1A","Sgn-liv1a"],"count":3,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000141424","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003968","MONDO_0007254"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL434374","canonicalSmiles":"O=C(O)CCCCCNC(=O)NC1CCCCC1","inchiKey":"KFTVEPYSUSWBRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-(3-Cyclohexylureido)Hexanoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-(3-Cyclohexylureido)Hexanoic Acid"],"crossReferences":{"drugbank":["DB08258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL443","canonicalSmiles":"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1","inchiKey":"JLKIGFTWXXRPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETHOXAZOLE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetylsulfamethoxazole","Gantanol","Gantanol-ds","Sinomin","Sulfamethoxazole","Suphamethoxazole","Urobak"],"synonyms":["Acetylsulfamethoxazole","NSC-147832","RO 4-2130","RO-4-2130","STX-608","Sulfamethoxazole","Sulfamethoxazole sodium","Sulphamethoxazole"],"crossReferences":{"DailyMed":["sulfamethoxazole"],"PubChem":["11112438","124882381","144204031","144207551","170464637","17388720","49734326","855654"],"Wikipedia":["Sulfamethoxazole"],"drugbank":["DB01015"],"chEBI":["9332"]},"count":25,"approvedIndications":["EFO_0003103","EFO_0007448","EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 4 approved and 21 investigational indications."}
{"id":"CHEMBL445420","canonicalSmiles":"O=C(Nc1ccccc1)c1cc[nH]n1","inchiKey":"WMZYZYFPPQOFKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL445420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14738661"],"drugbank":["DB08135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450044","canonicalSmiles":"CCOC(=O)OC[C@H]1O[C@@H](Oc2ccccc2Cc2ccc(OC)cc2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"QLXKHBNJTPICNF-QMCAAQAGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERGLIFLOZIN ETABONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW869682X","Sergliflozin","Sergliflozin etabonate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL450995","canonicalSmiles":"Oc1c(Br)cc(/C=C/c2ccccc2)cc1Br","inchiKey":"WMVYUPRIADVLTH-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL450995","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08101"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452329","canonicalSmiles":"CC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C","inchiKey":"IVCRCPJOLWECJU-XQVQQVTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRESTOLONE ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trestolone","Trestolone acetate","U-15,614"],"crossReferences":{"drugbank":["DB13958"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4571518","canonicalSmiles":"O=c1[nH]c(NCc2ccc(Cl)c(Cl)c2)nc2ncn(CCN3CCOCC3)c12","inchiKey":"DEGSGBKTODESHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBEZAPOLSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACX-362E","Acx-362e","Ibezapolstat"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4582651","canonicalSmiles":"CO[C@]1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CC[C@H](c2nc(C)cc(Nc3cc(C)[nH]n3)n2)CC1","inchiKey":"GBLBJPZSROAGMF-RWYJCYHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALSETINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BLU-123244","BLU-667","BLU123244","Blu-667","Pralsetinib","X-581238","X581238"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL458402","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C","inchiKey":"YYGNTYWPHWGJRM-AAJYLUCBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206342","144206790","50125918"],"Wikipedia":["Squalene"],"drugbank":["DB11460"],"chEBI":["15440"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594354","drugType":"Unknown","blackBoxWarning":false,"name":"ALMONERTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Almonertinib","Hs 10296","Hs-10296"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594460","drugType":"Unknown","blackBoxWarning":false,"name":"AT-1501","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-1501","At-1501"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594488","drugType":"Unknown","blackBoxWarning":false,"name":"POTASSIUM SODIUM HYDROGEN CITRATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium sodium hydrogen citrate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460499","canonicalSmiles":"CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O","inchiKey":"AOCCBINRVIKJHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMOFUR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carmofur"],"crossReferences":{"PubChem":["144205017","170465833","174006178","26749035"],"drugbank":["DB09010"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL477487","canonicalSmiles":"Nc1nc(O)c2ncn([C@H]3C[C@H](O)[C@@H](COP(=O)(O)O)O3)c2n1","inchiKey":"LTFMZDNNPPEQNG-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Deoxyguanosine 5'-Monophosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deoxyguanosine 5'-Monophosphate"],"crossReferences":{"drugbank":["DB04457"],"chEBI":["16192"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480","canonicalSmiles":"Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1","inchiKey":"MJIHNNLFOKEZEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANSOPRAZOLE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lansoprazole","Opiren","Prevacid","Prevacid 24 hr","Prevacid Delayed Release","Prevacid Solutab","Prevacid iv","Zoton"],"synonyms":["A-65006","AG-1749","Lansoprazole"],"crossReferences":{"DailyMed":["lansoprazole"],"PubChem":["11111389","11111390","124880589","124880592","144203735","144211340","170464649","174007196","26719660","26747053","50104195","50104197","56422192","57287635","85231117","855954","90341606"],"Wikipedia":["Lansoprazole"],"drugbank":["DB00448"],"chEBI":["6375"]},"count":21,"approvedIndications":["EFO_0003948","HP_0004398","EFO_0009454"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["HP_0001600","HP_0002239","EFO_0004274","MONDO_0007254","EFO_1000657","Orphanet_586","EFO_1001461","EFO_0003948","HP_0004398","EFO_0002506","MONDO_0002974","EFO_1000961","EFO_0003917","EFO_0000616","EFO_0009686","EFO_0000280","EFO_0000217","EFO_0004269","EFO_0004607","EFO_0003843","EFO_1001355","EFO_0008533","EFO_0004232","EFO_0009454","EFO_0000095","EFO_0000270","EFO_0001359","MONDO_0011962","Orphanet_758","EFO_0000574","EFO_0007456","EFO_1000270","EFO_1001095","EFO_0007415"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and has 3 approved and 18 investigational indications."}
{"id":"CHEMBL488","canonicalSmiles":"CCC1(c2ccc(N)cc2)CCC(=O)NC1=O","inchiKey":"ROBVIMPUHSLWNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOGLUTETHIMIDE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytadren","Orimeten"],"synonyms":["Aminoglutethimide","Cytadren"],"crossReferences":{"PubChem":["144203957","144213805","170465259","174007456","26747446","459146","46500462","50105852","85230926","90340970"],"Wikipedia":["Aminoglutethimide"],"drugbank":["DB00357"],"chEBI":["2654"]},"count":3,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000137869","ENSG00000140459"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","MONDO_0008315"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for neoplasm and has 2 investigational indications."}
{"id":"CHEMBL490867","canonicalSmiles":"COc1ccc(OC)c2c1c(C)cc(=O)n2C","inchiKey":"FTGZPMFPUDKJBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL490867","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08228"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492529","canonicalSmiles":"Cc1cc(Nc2ccc(C(F)(F)F)cc2)n2ncnc2n1","inchiKey":"LRHHXKBKRNNFRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DSM-74","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSM-74"],"crossReferences":{"drugbank":["DB08008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL504","canonicalSmiles":"C[S+](C)[O-]","inchiKey":"IAZDPXIOMUYVGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYL SULFOXIDE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["DMSO","Dimethyl sulfoxide","Domoso","Infiltrina","Rimso 50","Rimso-50","Syntexan"],"synonyms":["DMSO","Dimethyl sulfoxide","NSC-763","SQ 9453","SQ-9453"],"crossReferences":{"DailyMed":["dimethyl%20sulfoxide"],"PubChem":["144211274","26757375"],"Wikipedia":["Dimethyl_sulfoxide"],"drugbank":["DB01093"],"chEBI":["28262"]},"count":11,"approvedIndications":["HP_0002829","HP_0003326"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for arthralgia and myalgia and has 9 investigational indications."}
{"id":"CHEMBL513521","canonicalSmiles":"Cl.NCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"QLSODQWNKDAMMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BL-1020","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1187646","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BL-1020","Bl-1020"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL52247","canonicalSmiles":"CNCCCC1(c2ccccc2)SC(C)(C)c2ccccc21","inchiKey":"FKHYYOUFMJBLAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALSUPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talsupram"],"crossReferences":{"drugbank":["DB09191"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL537394","canonicalSmiles":"Cl.NCCNc1ccc(NCCN)c2c1C(=O)c1ccncc1C2=O","inchiKey":"NXSHYUUREPUCRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL537394","maximumClinicalTrialPhase":0,"parentId":"CHEMBL167731","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL600325","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MYEJFUXQJGHEQK-ALRJYLEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROSCILLARIDIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talusin","Tradenal"],"synonyms":["2936","A-32686","Proscillaridin"],"crossReferences":{"PubChem":["144203993","170465956"],"Wikipedia":["Proscillaridin"],"drugbank":["DB13307"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL600828","canonicalSmiles":"COc1c(O)ccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3","inchiKey":"UCLGCTLOEZZSLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"7-HYDROXY ARISTOLOCHIC A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02636"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL639","canonicalSmiles":"CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1","inchiKey":"MBUVEWMHONZEQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELASTINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Azelastine"],"crossReferences":{"DailyMed":["azelastine%20hydrochloride"],"Wikipedia":["Azelastine"],"drugbank":["DB00972"],"chEBI":["2950"]},"childChemblIds":["CHEMBL1200809"],"count":6,"approvedIndications":["EFO_0005751","HP_0001742","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0009364","EFO_0007533","EFO_0007141","EFO_0005751","EFO_1001417","HP_0001742","EFO_0003956","EFO_0003785"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL6444","canonicalSmiles":"Cc1cc(CCCCCOc2ccc(C3=NCCO3)cc2Cl)on1","inchiKey":"FCSKOFQQCWLGMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL6444","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08719"],"chEBI":["47727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL67776","canonicalSmiles":"CCc1cccc2c1c(O)c(C(=O)N(CC)c1ccccc1)c(=O)n2C","inchiKey":"DIKSYHCCYVYKRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAQUINIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABR-215757","Paquinimod"],"crossReferences":{"drugbank":["DB13118"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL70967","canonicalSmiles":"N#Cc1ccc(Nc2nc(N)nc(Oc3c(Cl)cccc3Cl)n2)cc1","inchiKey":"NFNNMVVXXITVGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-129385","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-129385"],"crossReferences":{"drugbank":["DB07343"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL717","canonicalSmiles":"CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"PSGAAPLEWMOORI-PEINSRQWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEDROXYPROGESTERONE ACETATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adgyn medro","Amen","Climanor","Curretab","Cycrin","Depo-progevera","Depo-provera","Depo-provera oncology","Depo-subq provera 104","Farlutal","Farlutal 100","Farlutal 200","Farlutal 250","Farlutal 500","Lunelle","Medroxyprogesterone acetate","Provera","Sayana press"],"synonyms":["Amen","Medroxiprogesterone acetate","Medroxyprogesterone","Medroxyprogesterone 17-acetate","Medroxyprogesterone Acetate","Medroxyprogesterone acetate","NSC-21171","NSC-26386","Prempro","Provera","TV-46046"],"crossReferences":{"DailyMed":["medroxyprogesterone%20acetate"],"PubChem":["144204872","144207339","170464622","17388931","26751478","56422500","855664"],"Wikipedia":["Medroxyprogesterone_acetate"],"drugbank":["DB00603"],"chEBI":["6716"]},"count":29,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001065","EFO_0007453","EFO_0000249","EFO_0000681","HP_0000132","HP_0031217","EFO_0003882","EFO_0002950","MONDO_0041161","EFO_1001375","EFO_0002690","HP_0008209","EFO_0000673","EFO_0000400","EFO_0003877","EFO_0000616","EFO_0000545","HP_0003124","EFO_0001645","EFO_0000180","EFO_0000319","EFO_0003843","EFO_0000537","MP_0001914","MONDO_0000831","EFO_0000764","MONDO_0011962","MONDO_0002367","Orphanet_881","EFO_0003922","EFO_1000233"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and is indicated for neoplasm and has 28 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL73962","canonicalSmiles":"NS(=O)(=O)c1nnc(NS(=O)(=O)c2ccccc2)s1","inchiKey":"PWDGTQXZLNDOKS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzolamide"],"crossReferences":{"drugbank":["DB07050"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL77101","canonicalSmiles":"CCNCCCCNCCCCNCCCCNCC","inchiKey":"QXOCYGPVDXDFLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLHOMOSPERMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethylhomospermine"],"crossReferences":{"drugbank":["DB13011"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL983","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]","inchiKey":"YOEWQQVKRJEPAE-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"SUCCINYLCHOLINE CHLORIDE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL703","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anectine","Quelicin","Quelicin preservative free","Scoline","Succinylcholine chloride","Sucostrin","Suxamethonium Chloride"],"synonyms":["NSC-49132","Succinylcholine chloride","Suxamethone","Suxamethonium chloride","Suxamethonium chloride dihydrate","Suxamethonium chloride hydrate"],"crossReferences":{"DailyMed":["succinylcholine%20chloride"],"PubChem":["144204820","170464625","50106980"],"Wikipedia":["Suxamethonium_chloride"],"chEBI":["61219"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_0002950"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1952. This drug has a black box warning from the FDA."}
